summaryrefslogtreecommitdiff
path: root/tools/eslint/node_modules/readline2/README.md
diff options
context:
space:
mode:
Diffstat (limited to 'tools/eslint/node_modules/readline2/README.md')
-rw-r--r--tools/eslint/node_modules/readline2/README.md33
1 files changed, 33 insertions, 0 deletions
diff --git a/tools/eslint/node_modules/readline2/README.md b/tools/eslint/node_modules/readline2/README.md
new file mode 100644
index 0000000000..5a677a4e6c
--- /dev/null
+++ b/tools/eslint/node_modules/readline2/README.md
@@ -0,0 +1,33 @@
+readline2 [![Build Status](https://travis-ci.org/SBoudrias/readline2.png?branch=master)](https://travis-ci.org/SBoudrias/readline2)
+=========
+
+Node.js (v0.8 and v0.10) had some bugs and issues with the default [Readline](http://nodejs.org/api/readline.html) module.
+
+This module include fixes seen in later version (0.11-0.12 and iojs) and ease some undesirable behavior one could see using the readline to create interatives prompts. This means `readline2` change some behaviors and as so is **not** meant to be an exact drop-in replacement.
+
+This project is extracted from the core of [Inquirer.js interactive prompt interface](https://github.com/SBoudrias/Inquirer.js) to be available as a standalone module.
+
+
+Documentation
+-------------
+
+**Installation**: `npm install --save readline2`
+
+### readline2.createInterface(options); -> {Interface}
+
+Present the same API as [Node.js `readline.createInterface()`](http://nodejs.org/api/readline.html)
+
+#### Improvements
+- Default `options.input` as `process.stdin`
+- Default `options.output` as `process.stdout`
+- `interface.stdout` is wrapped in a [MuteStream](https://github.com/isaacs/mute-stream)
+- Prevent `up` and `down` keys from moving through history inside the readline
+- Fix cursor position after a line refresh when the `Interface` prompt contains ANSI colors
+- Correctly return the cursor position when faced with implicit line returns
+
+
+License
+-------------
+
+Copyright (c) 2012 Simon Boudrias (twitter: [@vaxilart](https://twitter.com/Vaxilart))
+Licensed under the MIT license.